SCHEMBL7088751

SCHEMBL7088751

COc1ccc(CSCC[C@H](N)CN)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.45
SLC6A4 P31645 1/20 0.45
TAAR1 Q96RJ0 1/20 0.43
GAA P10253 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 1/20 0.42
MAOB P27338 2/20 0.40
APP P05067 1/20 0.40
AGXT P21549 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL672238 0.80 TAAR1 (0.57) IDO1SLC6A4TAAR1ALDH1A1SMN1; SMN2
Ammonia Solution, Strong SCHEMBL3027164 0.79 GAA (0.56) IDO1SLC6A4GAAALDH1A1SMN1; SMN2
SCHEMBL20394552 0.78 TAAR1 (0.60) SLC6A4TAAR1GAACYP1A2CYP2D6
Hydrochloric Acid SCHEMBL9371761 0.78 TAAR1 (0.55) IDO1SLC6A4TAAR1ALDH1A1SMN1; SMN2
SCHEMBL728403 0.76 IDO1 (0.56) IDO1SLC6A4TAAR1ALDH1A1SMN1; SMN2
SCHEMBL1586966 0.76 TAAR1 (0.56) SLC6A4TAAR1CYP1A2CYP2D6CYP2C19
SCHEMBL62037 0.75 IDO1 (0.59) IDO1SLC6A4TAAR1GAAALDH1A1
SCHEMBL1586261 0.74 SLC6A4 (0.66) IDO1SLC6A4TAAR1CYP1A2CYP2D6
SCHEMBL1586263 0.74 SLC6A4 (0.66) IDO1SLC6A4TAAR1CYP1A2CYP2D6
SCHEMBL1587009 0.74 TAAR1 (0.55) SLC6A4TAAR1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1332138-A1 RADIOPHARMACEUTICALS FOR DIAGNOSING ALZHEIMER'S DISEASE SCHERING AKTIENGESELLSCHAFT (DE) 2003-08-06 EP disclosed
WO-2002036581-A1 RADIOPHARMACEUTICALS FOR DIAGNOSING ALZHEIMER'S DISEASE SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-10 WO disclosed